Key result
Maternal SARS-CoV-2 exposure linked to neonatal multisystem inflammatory syndrome with ~90% cardiac involvement.
Why the study?
Maternal SARS-CoV-2 may potentially cause a hyperinflammatory syndrome in neonates similar to MIS-C due to transplacental transfer of antibodies.
Observational (n=20)
Yes
Maternal SARS-CoV-2 infection can result in transplacental antibody transfer causing a multisystem inflammatory syndrome in neonates (MIS-N) with prominent cardiac conduction disorders.
MIS-N after maternal SARS-CoV-2 exposure merits consideration in neonates with early cardiac issues; leaves open confirmation of incidence, causality, and therapy.
Multisystem inflammatory syndrome in children (MIS-C) is a post-infectious immune-mediated condition, seen 3-5 weeks after COVID-19. Maternal SARS-CoV-2 may potentially cause a similar hyperinflammatory syndrome in neonates due to transplacental transfer of antibodies. We reviewed the perinatal history, clinical features, and outcomes of 20 neonates with features consistent with MIS-C related to maternal SARS-CoV-2 in Kolhapur, India, from 1 September 2020 to 30 April 2021. Anti-SARS-CoV-2 IgG and IgM antibodies were tested in all neonates. Fifteen singletons and five twins born to eighteen mothers with a history of COVID-19 disease or exposure during pregnancy presented with features consistent with MIS-C during the first 5 days after birth. Nineteen were positive for anti-SARS-CoV-2 IgG and all were negative for IgM antibodies. All mothers were asymptomatic and therefore not tested by RTPCR-SARS-CoV-2 at delivery. Eighteen neonates (90%) had cardiac involvement with prolonged QTc, 2:1 AV block, cardiogenic shock, or coronary dilatation. Other findings included respiratory failure (40%), fever (10%), feeding intolerance (30%), melena (10%), and renal failure (5%). All infants had elevated inflammatory biomarkers and received steroids and IVIG. Two infants died. We speculate that maternal SARS-CoV-2 and transplacental antibodies cause multisystem inflammatory syndrome in neonates (MIS-N). Immunomodulation may be beneficial in some cases, but further studies are needed.
No takes yet. Share an insight, caveat, or question.
Pawar et al. (2021) conducted an observational in Neonatal Multisystem Inflammatory Syndrome (MIS-N) (n=20). Prenatal maternal SARS-CoV-2 infection or exposure was evaluated on Cardiac involvement (prolonged QTc, 2:1 AV block, cardiogenic shock, or coronary dilatation). Prenatal maternal SARS-CoV-2 exposure was associated with a novel neonatal multisystem inflammatory syndrome (MIS-N), manifesting with cardiac involvement in 90% of cases and a 10% mortality rate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: